Your browser does not support the audio format.
Medicare rejected a controversial Alzheimer’s drug. Participants still ended up paying for it.
by
Lily Jamali
Listen
Pause
LISTEN
HTML EMBED
Click to Copy
EMBED
EMBED
Download
Download
Marketplace Logo
Marketplace Logo